Requires medicaid and insurers to include coverage for testing of PFAS levels in blood
Do you support it?
Want to know if it passes?
We'll email you when A10211 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on A10211.
You're tracking A10211
We'll email you the moment it moves.
A10211 — Requires medicaid and insurers to include coverage for testing of PFAS levels in blood
Last action — In Assembly Committee
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the Assembly. Introduced February 12, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Requires medicaid and insurers to include coverage for testing of PFAS levels in blood; defines PFAS.
Bill Text
- Full text View text Current
Compared against the New York Consolidated Laws as published AI-generated reading aid — verify against the official bill.
This bill amends 1 section(s) of the New York Consolidated Laws: Section 3216 of the insurance law.
-
Section 3216 of the insurance law
(42) (A) Every policy which provides medical, major medical, or simi- lar comprehensive-type coverage shall provide coverage for testing of PFAS levels in blood if ordered by a physician or other licensed health care provider legally authorized to order such testing under title eight of the education law. (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl and polyfluoroalkyl substances. (24) (A) Every policy which provides medical, major medical, or simi- lar comprehensive-type coverage shall provide coverage for testing of PFAS levels in blood if ordered by a physician or other licensed health care provider legally authorized to order such testing under title eight of the education law. (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl and polyfluoroalkyl substances. (xx) (A) A medical expense indemnity corporation or a health service corporation which provides medical, major medical or similar comprehen- sive-type coverage shall include coverage for testing of PFAS levels in blood if ordered by a physician or other licensed health care provider legally authorized to order such testing under title eight of the educa- tion law. (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl and polyfluoroalkyl substances. italics (oo) (i) (1) Medical assistance shall include testing of PFAS levels in blood if ordered by a physician or other licensed health care provid- er legally authorized to order such testing under title eight of the education law. (2) For the purposes of this paragraph, "PFAS" means perfluoroalkyl and polyfluoroalkyl substances. (ii) In the event that federal financial participation for such test- ing of PFAS in blood is not available, medical assistance shall not include coverage of these services.
amended
Action History
-
REFERRED TO INSURANCE
Sponsors
- Anna Kelles · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does A10211 do?
- Requires medicaid and insurers to include coverage for testing of PFAS levels in blood; defines PFAS.
- Who sponsors A10211?
- A10211 is sponsored by Anna Kelles.
- What is the current status of A10211?
- This bill has been introduced in the Assembly. Introduced February 12, 2026. It must pass committee before a floor vote.
- Where can I track A10211?
- Track A10211 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on A10211
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of A10211
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →